申请人:Proximagen Limited
公开号:US08138333B2
公开(公告)日:2012-03-20
The present invention relates to novel compounds of formula (I):
wherein R1, R2, R3, R4, and R5 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HT6 receptor-related disorders.
本发明涉及公式(I)的新化合物:其中R1、R2、R3、R4和R5如本文所述,以及包含这些化合物的制药组合物,其制备过程,以及使用这些化合物制备针对5-HT6受体相关疾病的药物的用途。